日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy

肝细胞癌-胆管癌合并症的系统治疗：化疗、免疫疗法和靶向治疗的综合综述

期刊:Journal of Liver Cancer
影响因子:
doi:10.17998/jlc.2026.03.02
Hong, Jung Yong; Sinn, Dong Hyun; Ha, Sang Yun
肿瘤
肿瘤免疫
胆管癌
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Imaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advances

肝细胞癌、肝细胞-胆管混合癌和肝内胆管癌的影像学鉴别诊断：陷阱与进展

期刊:Journal of Liver Cancer
影响因子:
doi:10.17998/jlc.2026.03.05
Shin, Jaeseung; Chung, Taek; Ha, Sang Yun; Rhee, Hyungjin
细胞生物学
肿瘤
胆管癌
肿瘤免疫
发表日期：2026
文献求助 收藏

HELLS controls mitochondrial dynamics and genome stability in liver cancer by collusion with MIEF1.

HELLS 通过与 MIEF1 协同作用控制肝癌中的线粒体动力学和基因组稳定性

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07589-x
Choi Sung Kyung, Park Jihye, Ha Sang Yun, Kim Myoung Jun, Ahn Seor I, Kim Jeongah, Sun Woong, Park Yeong Min, Nam Suk Woo, Han Jeung-Whan, Kang Keunsoo, You Jueng Soo
肿瘤
肝癌
线粒体
发表日期：2025
文献求助 收藏

Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC

揭示与晚期肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗的临床反应相关的免疫激活肿瘤微环境

期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2024.101304
Lim, Jinyeong; Goh, Myung Ji; Song, Byeong Geun; Sinn, Dong Hyun; Kang, Wonseok; Gwak, Geum-Youn; Choi, Moon Seok; Lee, Joon Hyeok; Cha, Dong Ik; Gu, Kyowon; Ha, Sang Yun; Hwang, Inwoo; Park, Woong-Yang; Paik, Yong-Han
肿瘤
肿瘤免疫
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2025
文献求助 收藏

Comprehensive analysis of KRAS aberrations in pan-cancer, with a focus on prognostic and therapeutic implications

对泛癌中KRAS异常进行全面分析，重点关注其预后和治疗意义。

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251351438
Jung, Jaeyun; Hong, Jung Yong; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki; Lee, Jeeyun; Ha, Sang Yun; Ahn, Soomin; Lim, Sung Hee; Kim, Seung Tae
RAS
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Prognostic Role of Mitotic Index in Hepatocellular Carcinoma: Potential Clinical Implications for Very Early Stage Disease

有丝分裂指数在肝细胞癌预后中的作用：对极早期疾病的潜在临床意义

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S541099
Choi, Sangjoon; Cho, Yoon Ah; Park, Sujin; Koh, Hyun Hee; Park, Boram; Kim, Kyunga; Yang, Ju Dong; Ha, Sang Yun
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Histologic improvement predicts endoscopic remission in patients with ulcerative colitis

组织学改善可预测溃疡性结肠炎患者的内镜缓解

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-68372-0
Kim, Ji Eun; Kim, Minjee; Kim, Min-Ji; Kim, Eun Ran; Hong, Sung Noh; Chang, Dong Kyung; Ha, Sang Yun; Kim, Young-Ho
结肠炎
肠炎
发表日期：2024
文献求助 收藏

NADPH oxidase 4 deficiency promotes hepatocellular carcinoma arising from hepatic fibrosis by inducing M2-macrophages in the tumor microenvironment

NADPH氧化酶4缺乏通过诱导肿瘤微环境中的M2型巨噬细胞，促进肝纤维化引起的肝细胞癌的发生。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-72721-4
Kim, Ji Young; Kang, Wonseok; Yang, Sera; Park, Su Hyun; Ha, Sang Yun; Paik, Yong-Han
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2024
文献求助 收藏

Role of Lymphatic Embolization in Chylothorax Associated with Gorham-Stout Disease: A Case Report

淋巴栓塞术在戈勒姆-斯托特病相关乳糜胸中的作用：病例报告

期刊:
影响因子:
doi:10.3348/jksr.2023.0044
Yu, Min-Hyuk; Hyun, Dongho; Shin, Sun-Hye; Ha, Sang-Yun
发表日期：2024
文献求助 收藏

Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma

预测肝细胞癌患者免疫检查点抑制剂治疗反应的生物标志物

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms24087640
Ji, Jun Ho; Ha, Sang Yun; Lee, Danbi; Sankar, Kamya; Koltsova, Ekaterina K; Abou-Alfa, Ghassan K; Yang, Ju Dong
Checkpoint
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏